Literature DB >> 33197557

X-linked cellular mosaicism underlies age-dependent occurrence of seizure-like events in mouse models of CDKL5 deficiency disorder.

Barbara Terzic1, Yue Cui1, Andrew C Edmondson2, Sheng Tang3, Nicolas Sarmiento1, Daria Zaitseva1, Eric D Marsh4, Douglas A Coulter4, Zhaolan Zhou5.   

Abstract

CDKL5 deficiency disorder (CDD) is an infantile, epileptic encephalopathy presenting with early-onset seizures, intellectual disability, motor impairment, and autistic features. The disorder has been linked to mutations in the X-linked CDKL5, and mouse models of the disease recapitulate several aspects of CDD symptomology, including learning and memory impairments, motor deficits, and autistic-like features. Although early-onset epilepsy is one of the hallmark features of CDD, evidence of spontaneous seizure activity has only recently been described in Cdkl5-deficient heterozygous female mice, but the etiology, prevalence, and sex-specificity of this phenotype remain unknown. Here, we report the first observation of disturbance-associated seizure-like events in heterozygous female mice across two independent mouse models of CDD: Cdkl5 knockout mice and CDKL5 R59X knock-in mice. We find that both the prevalence and severity of this phenotype increase with aging, with a median onset around 28 weeks of age. Similar seizure-like events are not observed in hemizygous knockout male or homozygous knockout female littermates, suggesting that X-linked cellular mosaicism is a driving factor underlying these seizure-like events. Together, these findings not only contribute to our understanding of the effects of CDKL5 loss on seizure susceptibility, but also document a novel, pre-clinical phenotype for future therapeutic investigation.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  CDKL5; Mouse models of epilepsy; Neurodevelopmental disorders; Seizures; X-linked mosaicism

Mesh:

Substances:

Year:  2020        PMID: 33197557      PMCID: PMC7856307          DOI: 10.1016/j.nbd.2020.105176

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  42 in total

1.  Encephalopathy and bilateral cataract in a boy with an interstitial deletion of Xp22 comprising the CDKL5 and NHS genes.

Authors:  Hilde Van Esch; Anna Jansen; Marijke Bauters; Guy Froyen; Jean-Pierre Fryns
Journal:  Am J Med Genet A       Date:  2007-02-15       Impact factor: 2.802

2.  The CDKL5 disorder is an independent clinical entity associated with early-onset encephalopathy.

Authors:  Stephanie Fehr; Meredith Wilson; Jenny Downs; Simon Williams; Alessandra Murgia; Stefano Sartori; Marilena Vecchi; Gladys Ho; Roberta Polli; Stavroula Psoni; Xinhua Bao; Nick de Klerk; Helen Leonard; John Christodoulou
Journal:  Eur J Hum Genet       Date:  2012-08-08       Impact factor: 4.246

Review 3.  Cyclin-Dependent Kinase-Like 5 Deficiency Disorder: Clinical Review.

Authors:  Heather E Olson; Scott T Demarest; Elia M Pestana-Knight; Lindsay C Swanson; Sumaiya Iqbal; Dennis Lal; Helen Leonard; J Helen Cross; Orrin Devinsky; Tim A Benke
Journal:  Pediatr Neurol       Date:  2019-02-23       Impact factor: 3.372

Review 4.  Severity Assessment in CDKL5 Deficiency Disorder.

Authors:  Scott Demarest; Elia M Pestana-Knight; Heather E Olson; Jenny Downs; Eric D Marsh; Walter E Kaufmann; Carol-Anne Partridge; Helen Leonard; Femida Gwadry-Sridhar; Katheryn Elibri Frame; J Helen Cross; Richard F M Chin; Sumit Parikh; Axel Panzer; Judith Weisenberg; Karen Utley; Amanda Jaksha; Sam Amin; Omar Khwaja; Orrin Devinsky; Jeffery L Neul; Alan K Percy; Tim A Benke
Journal:  Pediatr Neurol       Date:  2019-03-27       Impact factor: 3.372

5.  Loss of CDKL5 disrupts kinome profile and event-related potentials leading to autistic-like phenotypes in mice.

Authors:  I-Ting Judy Wang; Megan Allen; Darren Goffin; Xinjian Zhu; Andrew H Fairless; Edward S Brodkin; Steve J Siegel; Eric D Marsh; Julie A Blendy; Zhaolan Zhou
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-10       Impact factor: 11.205

6.  AMPA Receptor Dysregulation and Therapeutic Interventions in a Mouse Model of CDKL5 Deficiency Disorder.

Authors:  Madhumita Yennawar; Rachel S White; Frances E Jensen
Journal:  J Neurosci       Date:  2019-04-05       Impact factor: 6.167

7.  CDKL5 and ARX mutations in males with early-onset epilepsy.

Authors:  Ghayda M Mirzaa; Alex R Paciorkowski; Eric D Marsh; Elizabeth M Berry-Kravis; Livija Medne; Asem Alkhateeb; Art Grix; Elaine C Wirrell; Berkley R Powell; Katherine C Nickels; Barbara Burton; Andrea Paras; Katherine Kim; Wendy Chung; William B Dobyns; Soma Das
Journal:  Pediatr Neurol       Date:  2013-05       Impact factor: 3.372

8.  Assessing reproductive status/stages in mice.

Authors:  Claudia S Caligioni
Journal:  Curr Protoc Neurosci       Date:  2009-07

9.  Aged heterozygous Cdkl5 mutant mice exhibit spontaneous epileptic spasms.

Authors:  Patrick J Mulcahey; Sheng Tang; Hajime Takano; Alicia White; Dayana R Davila Portillo; Owen M Kane; Eric D Marsh; Zhaolan Zhou; Douglas A Coulter
Journal:  Exp Neurol       Date:  2020-06-22       Impact factor: 5.620

10.  Incidence and phenotypes of childhood-onset genetic epilepsies: a prospective population-based national cohort.

Authors:  Joseph D Symonds; Sameer M Zuberi; Kirsty Stewart; Ailsa McLellan; Mary O'Regan; Stewart MacLeod; Alice Jollands; Shelagh Joss; Martin Kirkpatrick; Andreas Brunklaus; Daniela T Pilz; Jay Shetty; Liam Dorris; Ishaq Abu-Arafeh; Jamie Andrew; Philip Brink; Mary Callaghan; Jamie Cruden; Louise A Diver; Christine Findlay; Sarah Gardiner; Rosemary Grattan; Bethan Lang; Jane MacDonnell; Jean McKnight; Calum A Morrison; Lesley Nairn; Meghan M Slean; Elma Stephen; Alan Webb; Angela Vincent; Margaret Wilson
Journal:  Brain       Date:  2019-08-01       Impact factor: 13.501

View more
  6 in total

1.  Temporal manipulation of Cdkl5 reveals essential postdevelopmental functions and reversible CDKL5 deficiency disorder-related deficits.

Authors:  Barbara Terzic; M Felicia Davatolhagh; Yugong Ho; Sheng Tang; Yu-Ting Liu; Zijie Xia; Yue Cui; Marc V Fuccillo; Zhaolan Zhou
Journal:  J Clin Invest       Date:  2021-10-15       Impact factor: 14.808

2.  Flow blockage disrupts cilia-driven fluid transport in the epileptic brain.

Authors:  Regina J Faubel; Veronica S Santos Canellas; Jenna Gaesser; Nancy H Beluk; Tim N Feinstein; Yong Wang; Maya Yankova; Kalyani B Karunakaran; Stephen M King; Madhavi K Ganapathiraju; Cecilia W Lo
Journal:  Acta Neuropathol       Date:  2022-08-18       Impact factor: 15.887

3.  Deletion of a non-canonical regulatory sequence causes loss of Scn1a expression and epileptic phenotypes in mice.

Authors:  Jessica L Haigh; Anna Adhikari; Nycole A Copping; Tyler Stradleigh; A Ayanna Wade; Rinaldo Catta-Preta; Linda Su-Feher; Iva Zdilar; Sarah Morse; Timothy A Fenton; Anh Nguyen; Diana Quintero; Samrawit Agezew; Michael Sramek; Ellie J Kreun; Jasmine Carter; Andrea Gompers; Jason T Lambert; Cesar P Canales; Len A Pennacchio; Axel Visel; Diane E Dickel; Jill L Silverman; Alex S Nord
Journal:  Genome Med       Date:  2021-04-26       Impact factor: 11.117

Review 4.  CDKL5 deficiency disorder: molecular insights and mechanisms of pathogenicity to fast-track therapeutic development.

Authors:  Nicole J Van Bergen; Sean Massey; Anita Quigley; Ben Rollo; Alexander R Harris; Robert M I Kapsa; John Christodoulou
Journal:  Biochem Soc Trans       Date:  2022-08-31       Impact factor: 4.919

5.  Touchscreen cognitive deficits, hyperexcitability and hyperactivity in males and females using two models of Cdkl5 deficiency.

Authors:  Anna Adhikari; Fiona K B Buchanan; Timothy A Fenton; David L Cameron; Julian A N M Halmai; Nycole A Copping; Kyle D Fink; Jill L Silverman
Journal:  Hum Mol Genet       Date:  2022-09-10       Impact factor: 5.121

6.  Inhibition of microglia overactivation restores neuronal survival in a mouse model of CDKL5 deficiency disorder.

Authors:  Giuseppe Galvani; Nicola Mottolese; Laura Gennaccaro; Manuela Loi; Giorgio Medici; Marianna Tassinari; Claudia Fuchs; Elisabetta Ciani; Stefania Trazzi
Journal:  J Neuroinflammation       Date:  2021-07-08       Impact factor: 8.322

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.